Regulatory Situation of Herbal Medicines - A Worldwide Review
(1998; 49 pages) [French] [Spanish] View the PDF document
Table of Contents
View the documentFOREWORD
Open this folder and view contentsI. INTRODUCTION
Open this folder and view contentsAfrica
Open this folder and view contentsThe Americas
Open this folder and view contentsEastern Mediterranean
Open this folder and view contentsEurope
Close this folderSouth East Asia
View the documentIndia
View the documentIndonesia
View the documentNepal
View the documentThailand
Open this folder and view contentsWestern Pacific
View the documentIII. CONCLUSION
View the documentIV. REFERENCES


Herbal medicines have to be registered by the Department of Drug Administration, at the Ministry of Health. Regulatory requirements are: manufacturing licences issued by the concerned Drug Control Authority, price approval and valid price list, letter of warranty of the manufacturer indicating his/her responsibility for safety, efficacy and quality of his products, authorization for import, export and distribution of the product, and the mode of distribution and promotion. Pharmaceutical requirements are the quantitative formula including all excipients, stability data, shelf-life, bioavailability in vitro and in vivo, wherever applicable, a description of the product including container and labelling, and a photograph of each product. For medicinal plants, permission is given by the Department of Forests [122].

to previous section
to next section
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: December 6, 2017